Ctcf and ctcfl in cancer

Author: cryt

August undefined, 2024

WebNov 2, 2024 · However, in cancer, CTCF is substituted by CTCFL/BORIS, depicted as a blue circle, shutting down the transcription of these tumor suppressor genes through activation of anti-sense transcripts. The … WebFeb 16, 2024 · CTCF overexpression has been identified in breast cancer , cervical cancer , ovarian cancer , and hepatocellular carcinoma . Some mutations are related to tumors ( 15 ). In particular, hotspot binding site mutations occur at quite a high frequency (25%) in GC, and these mutations are associated with alterations in gene expression ( 16 ).

CTCF and CTCFL in cancer Request PDF - ResearchGate

WebAug 7, 2024 · Main. Unlike CTCF, which is uniformly expressed in healthy tissues and cancer cells, the expression of BORIS is typically restricted to the testis 6 and embryonic stem cells 11 (Extended Data Fig ... WebResearch to identify CTCFL as a biomarker for specific cancer types and for therapeutical approaches has been followed up . With the advent of next-generation-sequencing many advances in the field of DNA binding factors have been made. ... CTCF/CTCFL co-bound and CTCF or CTCFL stand-alone sites) and the average CTCF site as reference were ... how do you spell usually correctly

MYC reshapes CTCF-mediated chromatin architecture in prostate cancer …

WebCTCF-mediated enhancer blocking is conserved from Drosophila to man (Moon et al. 2005) Antisense transcription of triplet repeats is constrained by CTCF (Cho et al. 2005) Boundaries between X inactivation and escape of inactivation bind CTCF (Filippova et al. 2005) CTCF antagonizes with CTCFL at the cancer testis gene MAGE-A1 (Vatolin et al. … WebAug 12, 2024 · In this regard, BORIS (CTCFL), a CTCF paralog, is a promising cancer biomarker that is overexpressed and controls … WebApr 13, 2024 · MYC reshapes CTCF-mediated chromatin architecture in prostate cancer. April 13, 2024. MYC is a well characterized oncogenic transcription factor in prostate … how do you spell useage

CTCF and CTCFL mRNA expression in 17β-estradiol‑treated MCF7 …

Defining the relative and combined contribution of CTCF and CTCFL …

WebMay 11, 2024 · Ubiquitously expressed CTCF is involved in numerous cellular functions, such as organizing chromatin into TAD structures. In contrast, its paralog, CTCFL, is normally only present in the testis. However, it is also aberrantly expressed in many cancers. While it is known that shared and unique zinc finger sequences in CTCF and CTCFL … WebOct 1, 2024 · Using the Kaplan Meier plotter the prognostic significance of mRNA levels of CTCFL in gastric, breast, and ovarian cancer were interrogated, similarly to the respective levels of CTCF. In gastric cancer high CTCFL mRNA expression levels are associated with worse OS compared with gastric cancers having low CTCFL mRNA expression (HR = … how do you spell usuallyWebApr 4, 2024 · CTCF provided by HGNC Official Full Name CCCTC-binding factor provided by HGNC Primary source HGNC:HGNC:13723 ... LncRNA PCGEM1 promotes colorectal cancer cell proliferation and migration in positive feedback loop through PCGEM1/miR-433-3p/CTCF axis. ... CTCFL paralog. NCBI Reference Sequences (RefSeq) Go to the top of … how do you spell user

"WebApr 1, 2024 · CTCF and CTCFL contain N-terminal and C-terminal domains and a central 11-zinc finger region. CTCF binds to approximately 80 000 sites on mammalian … " - Ctcf and ctcfl in cancer

Ctcf and ctcfl in cancer

WebThe LOF of CTCF or cohesin in cancer may cause activation of oncogenes through altering chromatin loops (Fig. 4). CTCF is frequently mutated in endometrial carcinoma, head … WebIn ovarian cancer CTCFL expression indeed correlates with advanced stage and decreased survival . In other tumor types CTCFL expression has also been detected, although expression data have been contradictory . According to the TCGA data, CTCFL is mainly expressed in ovarian cancer (Supplementary Figure 2).

Did you know?

WebSmits et al. report that TLX3 chromosomal translocations in T cell acute lymphoblastic leukemia patients recurrently include intervening CTCF-binding sites in the breakpoint area. Pressure to acquire inactivating aberrations in CTCF abrogate consequential enhancer insulation that promotes TLX3 promoter to BCL11B enhancer looping boosts higher … WebOct 5, 2024 · BORIS (CTCFL) is a DNA binding protein which is involved in tumorigenesis. Although, there are different opinions on the level of gene expression and function of BORIS in normal and cancer tissues, the results of many studies have classified BORIS as a protein belonging to cancer/testis (CT) genes, which are identified as a group of genes …

WebNational Center for Biotechnology Information WebApr 1, 2024 · In this regard, BORIS (CTCFL), a CTCF paralog, is a promising cancer biomarker that is overexpressed and controls transcription in several cancer types, …

WebCancer remains the main cause of human death worldwide, and most cancers still lack effective prevention and treatment means ... that DTL interacted with arsenic trioxide, aflatoxin b1, MLN7243 and palmitic acid. In addition, NRF1, E2F4, STAT3, CTCF, CTCFL and E2F1 were predicted to be the interacting targets. Hsa-miR-330-3p, hsa-miR ... WebAug 31, 2016 · A common aberration in cancer is the activation of germline-specific proteins. The DNA-binding proteins among them could generate novel chromatin states, not found in normal cells. The germline-specific transcription factor BORIS/CTCFL, a paralog of chromatin architecture protein CTCF, is often erroneously activated in cancers and …

WebNov 15, 2013 · Estrogens play a key role in breast cancer, with 60-70% of the cases expressing estrogen receptors (ERs), which are encoded by the ESR1 gene. CTCFL, a paralogue of the chromatin organizer CTCF, is a potential biomarker of breast cancer, but its expression in this disease is currently controversial. A positive correlation has been …

WebNov 15, 2013 · Estrogens play a key role in breast cancer, with 60–70% of the cases expressing estrogen receptors (ERs), which are encoded by the ESR1 gene. CTCFL, a paralogue of the chromatin organizer CTCF, is a potential biomarker of breast cancer, but its expression in this disease is currently controversial. how do you spell usingWebFeb 7, 2024 · The oncogene CTCFL (BORIS), the paralog of CTCF, is a transcriptional factor highly expressed in ovarian cancer (but in rarely any other tissue in females) with cancer-specific characteristics and ... how do you spell utilityWebMay 11, 2024 · Ubiquitously expressed CTCF is involved in numerous cellular functions, such as organizing chromatin into TAD structures. In contrast, its paralog, CTCFL, is … how do you spell use toWebIn ovarian cancer CTCFL expression indeed correlates with advanced stage and decreased survival . In other tumor types CTCFL expression has also been detected, although … phones at ee storeWebSep 15, 2024 · Identification of cancer-specific CTCF binding patterns in the human genome. a Distribution of coefficient of variation of chromatin accessibility at different genomic features, calculated using DNase-seq data from over 60 cell lines from ENCODE.b Distribution of occupancy score for all 688,429 union CTCF binding sites (blue), and … how do you spell utilizedWebJun 15, 2005 · Abstract. CTCF is a candidate tumor suppressor gene encoding a multifunctional transcription factor. Surprisingly for a tumor suppressor, the levels of CTCF in breast cancer cell lines and tumors were found elevated compared with breast cell lines with finite life span and normal breast tissues. In this study, we aimed to investigate the … phones at flowWebSep 15, 2024 · Background: The three-dimensional genome organization is critical for gene regulation and can malfunction in diseases like cancer. As a key regulator of genome … phones at franko